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Understanding how RNA binding proteins control
the splicing code is fundamental to human biology
and disease. Here, we present a comprehensive
study to elucidate how heterogeneous nuclear ribo-
nucleoparticle (hnRNP) proteins, among the most
abundant RNA binding proteins, coordinate to regu-
late alternative pre-mRNA splicing (AS) in human
cells. Using splicing-sensitive microarrays, cross-
linking and immunoprecipitation coupled with
high-throughput sequencing (CLIP-seq), and cDNA
sequencing, we find that more than half of all AS
events are regulated by multiple hnRNP proteins
and that some combinations of hnRNP proteins
exhibit significant synergy, whereas others act
antagonistically. Our analyses reveal position-
dependent RNA splicing maps, in vivo consensus
binding sites, a surprising level of cross- and autor-
egulation among hnRNP proteins, and the coordi-
nated regulation by hnRNP proteins of dozens of
other RNA binding proteins and genes associated
with cancer. Our findings define an unprecedented
degree of complexity and compensatory relation-
ships among hnRNP proteins and their splicing
targets that likely confer robustness to cells.INTRODUCTION
Nascent transcripts produced by RNA polymerase II in eukary-
otic cells are subject to extensive processing prior to the gener-
ation of a mature messenger RNA (mRNA). In human cells, a
sizable fraction of these precursor mRNAs (pre-mRNAs) is asso-
ciated with heterogeneous nuclear ribonucleoparticle (hnRNP)
proteins, forming large hnRNP-RNA complexes (Dreyfuss et al.,
1993). These complexes can contain any combination of at least
20 major hnRNP proteins named hnRNP A1 through hnRNP U.CRivaling histones in their abundance, hnRNP proteins assem-
ble on pre-mRNAs in a combinatorial arrangement dictated
by their relative abundances and recognition of specific RNA
sequences (Dreyfuss et al., 2002).
HnRNP proteins are multifunctional, participating in all crucial
aspects of RNA processing, including pre-mRNA splicing,
mRNA export, localization, translation, and stability (Han et al.,
2010). Of particular interest is the increasingly evident impact
of hnRNP proteins on the regulation of alternative splicing
(AS), in which splice sites within a pre-mRNA are preferentially
selected or repressed to produce different mRNA isoforms.
The process of AS contributes drastically to proteome diversity;
recent estimates suggest that greater than 90% of human
genes can undergo AS (Wang et al., 2008). The proper control
of AS is essential for cellular development and homeostasis.
Consequently, misregulation of specific AS events has been
shown to result in several diseases, such as spinal muscular
atrophy (Kashima and Manley, 2003), and global misregulation
of AS has been shown to occur in multiple forms of cancer (Gar-
dina et al., 2006; Lapuk et al., 2010; Misquitta-Ali et al., 2011). In
addition, hnRNP proteins are misregulated in particular cancer
cell types and have been shown to directly affect AS events
that promote cancer (David et al., 2010; Golan-Gerstl et al.,
2011).
Most hnRNP proteins have been implicated in AS; however,
a majority of these reports were based on single-gene studies
and in vitro assays. The first systematic AS analysis for the
hnRNP protein family used siRNAs against 14 of the major
hnRNP proteins in three different human cell lines, followed by
an RT-PCR screen restricted to 56 AS events (Venables et al.,
2008). Recent advances in genome-wide technologies have
allowed for more global assessments of AS. The use of
splicing-sensitive microarrays or RNA sequencing (RNA-seq)
to identify genome-wide AS events (Katz et al., 2010) in combi-
nation with the use of biochemical approaches such as iCLIP
(Ko¨nig et al., 2010) and CLIP-seq (Katz et al., 2010) have identi-
fied functional binding sites for hnRNP C and hnRNP H1,
respectively. In Drosophila, genome-wide AS changes were
identified for the orthologous hnRNP A/B family and, combined
with immunoprecipitation strategies, revealed that the fourell Reports 1, 167–178, February 23, 2012 ª2012 The Authors 167
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Figure 1. Thousands of hnRNP-Dependent
Alternative Splicing Events Identified in
Human Cells
(A) Western analysis demonstrating successful
depletion of hnRNP proteins A1, A2/B1, F, H1, M,
and U in human 293T cells in triplicate experi-
ments. GAPDH was used as a loading control. The
extent of protein depletion was quantified by
densitometric analysis.
(B) Experimental strategy for identification of
AS events. Total RNA was extracted from hu-
man 293T cells treated with (1) hnRNP-targeting
siRNA(s) or (2) a control nontargeting siRNA and (3)
was subjected to splicing-sensitive microarrays
(probes depicted in green).
(C) Pie charts of differentially regulated AS events
as detected by splicing arrays. Colors represent
the types of AS events that were detected, and the
size of each pie chart reflects the number of events
detected.
(D) Cassette exons differentially regulated upon
depletion of individual hnRNP proteins, relative to
control. Bars are divided to display the proportion
of events that are less included upon depletion
(hnRNP-activated, light gray) or more included
upon depletion (hnRNP-repressed, dark gray).
(E) RT-PCR validation of hnRNP A1-regulated
cassette exons (p < 0.01, t test). Absolute separa-
tion score predicted by the splicing array analysis is
listed below the affected gene name. Bar plots
represent densitometric analysis of bands, and
error bars represent SD in triplicate experiments.
(See also Figure S1.)hnRNP family members tested bound and regulated a set of
overlapping, but distinct, target RNAs (Blanchette et al., 2009).
Nevertheless, it is unknown whether this mode of coregulation
is conserved in humans.
In this study, we used genome-wide approaches to identify
hnRNP-regulated AS events in human cells and examined
the impact of their regulation. Using siRNAs to deplete the
protein levels of six major hnRNP proteins—A1, A2/B1, F,
H1, M, and U—and splicing-sensitive human exon-junction
microarrays (Affymetrix HJAY), we have identified thousands
of hnRNP-dependent exons. A battery of analyses demon-
strated that the majority of hnRNP-dependent AS events are
regulated by multiple hnRNP proteins and that depletion of168 Cell Reports 1, 167–178, February 23, 2012 ª2012 The Authorsindividual members of a set of hnRNP
proteins acts to cause similar sets of AS
changes. Using antibodies specific for
hnRNP proteins A1, A2/B1, F, M and U,
we performed CLIP-seq (or HITS-CLIP)
to identify direct binding sites that
contribute to the regulation of AS events.
The combination of our data revealed six
interrelated RNA splicing maps for the
major hnRNP proteins. Finally, RNA-seq
was used to show that hnRNP proteins
regulate a significant subset of RNA
binding proteins (RBPs) and cancer-associated genes, implicating hnRNP proteins in the regulation
of other aspects of RNA processing and general pathways
in cancer.
RESULTS
Identification of Thousands of hnRNP-Dependent
Human AS Events
To identify genome-wide AS events regulated by hnRNP
proteins, we reduced the protein levels of hnRNP proteins A1,
A2/B1, F, H1, M, and U to 8%–28% of their endogenous levels
in human 293T cells (Figure 1A). Splicing-sensitive microarrays
were used to discover AS events that change significantly upon
depletion of specific hnRNP proteins relative to a nontargeting
control siRNA (Figure 1B). Hierarchical clustering of normalized
intensities for all microarrays showed that the triplicate exper-
iments for specific hnRNP depletions group together appro-
priately (Figure S1A). Using a published analysis procedure
(Sugnet et al., 2006), we identified 6,555 altered AS events
upon hnRNP depletion, representing 4,638 human genes.
This widespread regulation of AS events is consistent with
the reported splicing regulatory roles of hnRNP proteins A1,
A2/B1, F, H1, and M (Figure 1C). Depletion of the well-studied
splicing regulator hnRNP A1 affected the largest number of AS
events (2,576). Surprisingly, depletion of hnRNP U, which
previously showed little evidence for splicing regulation (Marti-
nez-Contreras et al., 2007), affected almost as many AS
events (2,418) as hnRNP A1. As hnRNP proteins affected
different types of AS in similar ratios (Figure 1C), we focused
our analysis on the most represented category, cassette
exons, in which a single exon was either included or skipped
from a mature mRNA transcript. In total, the inclusion of
2,586 cassette exons was affected by hnRNP protein deple-
tion, ranging from 546 exons for hnRNP F to 1,116 exons for
hnRNP U. Thus far, this data set contains thousands more
human AS events whose splicing regulation is dependent on
hnRNP proteins than previously published hnRNP studies
(Katz et al., 2010; Ko¨nig et al., 2010; Llorian et al., 2010; Ven-
ables et al., 2008; Xue et al., 2009).
HnRNP Proteins Activate and Repress Cassette Exons
To provide insight into whether hnRNP proteins activate or
repress exon recognition, we determined what fraction of exons
showed increased inclusion (or exclusion) when a particular
hnRNP was depleted, a response expected for exons repressed
(or activated) by the regulator. By this criterion, hnRNP proteins
A1 and A2/B1 repress the largest fractions of cassette exons
(Figure 1D). This is consistent with splicing repression by hnRNP
A1 and A2/B1 (Martinez-Contreras et al., 2007); however, their
presence also appears necessary for exon inclusion. In fact,
hnRNP proteins F, H1, M, and U appear to activate exon inclu-
sion for a majority of the cassette exons they affect (Figure 1D).
The same trend is also observed for other types of AS events, in
which after depletion, more than half of the events dependent on
hnRNP F, H1, M, and U show increased skipping and more than
half of the events dependent on hnRNP A1 and A2/B1 show
increased inclusion. Semiquantitative RT-PCR experiments
successfully validated 89% of the 84 cassette exon events
tested, a rate consistent with previous reports using this plat-
form (Du et al., 2010; Polymenidou et al., 2011; Sugnet et al.,
2006) (see Figure 1E for select hnRNP A1-dependent events
and Figures S1B–S1G for additional events tested). Splicing
changes in 293T cells were reproduced when we depleted
hnRNP A2/B1 with an antisense oligonucleotide in primary
human fibroblasts (Figures S1H and S1I), indicating that the
regulation of many of these AS events is preserved in primary
human cells. Thus, we conclude that these six hnRNP proteins
act both as repressors and activators of exon inclusion and
are important for maintaining correct levels of inclusion of
hundreds to thousands of differentially spliced AS events in
the human transcriptome.CMultiple hnRNP Proteins Regulate a Majority
of AS Events in a Hierarchy of Collaboration
The high abundance of hnRNP proteins in human cells suggests
that a considerable level of multiplicity or redundancy is likely to
exist for regulation of RNA processing. Indeed, more than half
(54%) of the 2,586 differentially spliced cassette exons were
affected by more than one hnRNP protein, recapitulated also in
the other types of AS events (Figure 2A). Moreover, 47% of the
1,407 shared cassette exons were affected by three or more
hnRNP proteins (Figure 2B). These global observations in human
cells are confirmed by studies of individual AS events, such as
the c-src cassette exon N1, which is regulated by hnRNP F,
hnRNP H1, PTB (hnRNP I), and hnRNP A1 (Black, 2003), as
well as a study of the hnRNP A/B subfamily in a Drosophila cell
line (Blanchette et al., 2009). With the use of thousands of AS
events, our findings demonstrate that hnRNP proteins act in a
concerted manner at many events in human cells.
We then set out to identify relationships between hnRNP
proteins and the sets of cassette exons they regulate. Hierar-
chical clustering across regulated cassette exon sets revealed
that activities of hnRNP A1 and M are the most distinct among
the six hnRNP proteins (Figure 2C, dendrogram). To examine
each relationship, we counted the percentage of cassette exons
regulated independently by pairs of hnRNP proteins, termed
‘‘overlapping events.’’ To illustrate, 29% of cassette exons
affected by depletion of hnRNP M are also affected by deple-
tion of hnRNP A2/B1 (Figure 2C, row 6, column 1, sum of
percentages), and correspondingly, 19% of cassettes affected
by depletion of hnRNP A2/B1 are also affected by M (Figure 2C,
row 1, column 6, sum of percentages). HnRNP F and H1 have
very similar protein domain structures and bind to the samemotif
(Caputi and Zahler, 2001), which correlates with their significant
fraction of overlapping events (206 total; p < 0.05, hypergeo-
metric test). HnRNP A1 and A2/B1 also have similar protein
domain structures; however, we observed only a modest frac-
tion of overlapping events (330 total; Figure 2C). Instead, we
observed significant fractions of overlapping events regulated
between hnRNP proteins A2/B1 and H1, A2/B1 and F, and F
and U (Figure 2C, solid lined circles). These results identify novel
relationships between hnRNP proteins in AS regulation.
To determine whether pairs of hnRNP proteins might act in
concert or antagonistically, we noted the direction of change
generated by each pair for each of their overlapping events.
We found that most changed in the same direction (76% of
targets, on average, across all pair-wise comparisons). In fact,
a significant fraction of the changes in 11 of the 15 pair-wise
comparisons of hnRNP-regulated cassette exons were in the
same direction (p < 0.002, hypergeometric test; Figure 2C, high-
lighted in yellow), implying that multiple hnRNP proteins gener-
ally act in concert to modulate exon inclusion. Notably, 62% of
the overlapping events between hnRNP F and H1 and 73% of
the overlapping events between hnRNP F and U were activated
upon depletion of either protein. RT-PCR confirmed 14 examples
of cooperative AS regulation by hnRNP F andU,manywith direct
evidence for binding for the hnRNP proteins in the proximity of
the exon (Figure 2D; Figure S2A). Of all pair-wise comparisons,
hnRNP A1 andM regulated a more distinct set of cassette exons
in comparison with the other hnRNP proteins, and they showedell Reports 1, 167–178, February 23, 2012 ª2012 The Authors 169
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Figure 2. Multiple hnRNP Proteins Coregulate AS Events
(A) For each type of AS event, the percentage of events that was affected in more than one hnRNP depletion (colored black), and the percentage of events that
was affected uniquely in a single hnRNP depletion is shown.
(B) Distribution of shared cassette exons affected by 2–6 hnRNP proteins.
(C) Comparisons of the overlap and directionality of cassette exons affected by pairs of hnRNP proteins. The dendrogram displays the hierarchical clustering of all
cassette exons regulated by each hnRNP protein. Circles represent the percentage of overlapping events for the hnRNP in the row, with the hnRNP listed in the
column. Circles with gray shading indicate overlapping events that were affected in opposing directions (depletion of one hnRNP protein leads to inclusion and
depletion of the other hnRNP leads to skipping). For cassette exons that were affected in the same direction, blue values indicate the percentage of events that
were hnRNP-activated while values in gray listed below represent the percentage that were hnRNP-repressed. The solid black lines represent significant overlap
of targets (p < 0.05, hypergeometric test) and the yellow highlighting denotes overlapping cassettes that are significantly changing in the same direction (p <
0.002, hypergeometric test). The dashed-line box contains the hnRNP proteins that are most similar.
(D) RT-PCR validations of cassette exons affected in the same direction upon depletion of hnRNP F or hnRNP U (p < 0.01, t test). Binding of hnRNP F and U near
the cassette exon is shown below.
(E) RT-PCR validation of a cassette exon similarly affected by depletion of hnRNP A1 or hnRNPM, but opposite from the change caused by depletion of hnRNPU
(p < 0.05, t test).
In (D) and (E), the absolute separation score, as predicted by the splicing array analysis, is listed above the bars. Bar plots represent densitometric analysis of
bands, and error bars represent SD in triplicate experiments.
(See also Figure S2.)fewer overlapping events in the same direction (Figure 2C). We
also validated three events in which hnRNP A1 acted antagonis-
tically to hnRNP U (Figure S2B), two events in which hnRNP A1
and M acted similarly (Figure S2C), and one event in which
hnRNP A1 and M acted similarly but antagonistically to hnRNP
U (Figure 2E). We conclude that indirectly or directly, hnRNP
proteins A2/B1, H1, F, and U act cooperatively to regulate AS
in similar ways, while hnRNP proteins A1 and M more frequently
influence changes in opposition from the other hnRNP proteins.
Mapping Sites of Physical Interaction among Six hnRNP
Proteins and 10,000 Pre-mRNAs
The complex regulation observed above could be achieved
by a number of indirect mechanisms. To determine whether
joint regulation by hnRNP proteins involves direct binding by170 Cell Reports 1, 167–178, February 23, 2012 ª2012 The Authorsmultiple proteins, we identified RNA binding sites of the hnRNP
proteins using CLIP-seq. HnRNP proteins have been shown to
bind degenerate RNA sequences that are relatively short (4–5
nucleotides in length), rendering identification of binding sites
by solely bioinformatic means unreliable. Instead, CLIP
employs immunoprecipitation of crosslinked protein-RNA com-
plexes to purify and sequence RNA regions bound to the pro-
tein of interest, and despite inherent limitations of specificity
common to immunoprecipitation-based methods, CLIP has
been successfully used to identify direct binding sites across
many cell types, tissues, and organisms (Chi et al., 2009; Haf-
ner et al., 2010; Ko¨nig et al., 2010; Licatalosi et al., 2008;
Mukherjee et al., 2011; Polymenidou et al., 2011; Sanford
et al., 2009; Yeo et al., 2009). We performed CLIP-seq for
hnRNP A1, A2/B1, F, M, and U (Figure S3A, Table S1), yielding
AB C
Figure 3. HnRNP Proteins Bind to Sequence Motifs In Vivo and Are Enriched Near Regulated Exons
(A) Distribution of hnRNP binding sites within different categories of genic regions (pie charts). Bar plots represent the fraction of a particular region bound, relative
to the total genomic size of the region. The most representative top motifs identified by the HOMER algorithm are also shown.
(B) Preference for hnRNP protein binding near EST or mRNA-defined cassette exons. The y axis is the log2 ratio of the fraction of 41,754 cassette exons to the
fraction of 222,125 constitutive exons harboring hnRNP binding clusters within 2 kb of the exon. All ratios are significant (p < 1028, Fisher exact test).
(C) Preference for hnRNP proteins to bind near splicing array-defined cassette exons that are activated or repressed by a specific hnRNP protein. The y axis is the
log2 ratio of the fraction of changed cassette exons to the fraction of unchanged cassette exons having hnRNP binding clusters within 2 kb of the exon. Dark gray
bars represent the preference for hnRNP-repressed compared to unaffected exons, and light gray bars represent the preference for hnRNP-activated compared
to unaffected exons. A single asterisk denotes the most significant binding preference (p < 0.05, Fisher exact test).
(See also Figure S3.)comparable results to data generated for hnRNP H1 (Katz
et al., 2010), which we incorporated with our own to generate
a complete set of CLIP-seq data for the hnRNP proteins of
interest.
A total of 85,921 CLIP-derived clusters (CDCs) were identified,
representing binding sites for six hnRNP proteins in 10,557
protein-coding genes (Table S1). These binding sites are distrib-
uted uniformly across pre-mRNA sequences, with the exception
of hnRNPM, which shows a 50 bias (Figure S3B). HnRNP binding
sites are predominantly intronic, occurring within 500 nt of an
exon (proximal intron), as expected for splicing regulators, but
also in intronic regions further than 500 nt from an exon (distal
intron, Figure 3A, pie charts). Accounting for the total length of
the region reveals enrichment for binding within exonic regions
and 30 untranslated regions (UTRs) for hnRNP A1, A2/B1, F,
and U (Figure 3A, bar plots). The enrichment is consistent with
the continuous shuttling of most hnRNP proteins from the
nucleus to the cytoplasm and can mediate gene regulation via
other RNA processing events such as transport and stability
(Dreyfuss et al., 2002). HnRNP M demonstrates a strongerCpreference for binding in distal intronic regions, resembling that
of another member of the hnRNP family, TDP-43, in mouse brain
(Polymenidou et al., 2011). The distributions of hnRNP binding
sites in different genic regions indicate that hnRNP proteins, in
particular hnRNPM, are likely to have additional RNA processing
functions other than splicing regulation.
In Vivo hnRNP Sequence Motifs and Enrichment near
Regulated Exons
HnRNP proteins frequently recognize degenerate RNA se-
quences, as determined from affinity purification and SELEX
(systematic evolution of ligands by exponential enrichment)
experiments to identify the in vitro binding motif of the proteins
(Burd and Dreyfuss, 1994; Swanson and Dreyfuss, 1988). The
HOMER algorithm (Heinz et al., 2010) was applied to each set
of hnRNP CDCs to discover the in vivo binding motifs of each
hnRNP protein (two representatives of the four most significantly
enriched motifs in Figure S3C are depicted in Figure 3A).
For hnRNP A1, the predicted UAG(G) motif resembles the
well-characterized UAGG hnRNP A1 binding site (Hutchisonell Reports 1, 167–178, February 23, 2012 ª2012 The Authors 171
et al., 2002). For hnRNP A2/B1, not only did we recover the UAG
sequence among the most significantly enriched motifs, but we
also identified aG/A-richmotif similar to the previously published
UAGRGA motif (Hutchison et al., 2002). HnRNP F binds fairly G-
rich sequences similar to the known in vitro GGGA motif (Caputi
and Zahler, 2001). Additional G-rich motifs with interspersed
uridines and adenosines are also enriched for hnRNP F, which
is consistent with the motifs identified in SELEX experiments
coupled with high-throughput sequencing (Zefeng Wang,
personal communication). HnRNP H1 binds G-rich sequences
interspersed with adenosines, which is very similar to its known
GGGA motif (Caputi and Zahler, 2001; Katz et al., 2010). HnRNP
Mbinds to GU-rich sequences that often contain a UU sequence
within the motif, corroborating with in vitro observations that
hnRNP M interacts with poly-U and poly-G sequences (Datar
et al., 1993). HnRNP U CDCs are enriched for GU-rich se-
quences, also in agreement with a previous report showing
that poly-U and poly-G sequences were the preferred in vitro
binding sequences for hnRNP U (Kiledjian and Dreyfuss, 1992).
Next, we studied hnRNP binding sites near all annotated
exons categorized as either constitutive or AS on the basis of
available expressed sequence tag (EST) or mRNA transcript
evidence. A distance of 2 kilobases (kb) up- and downstream
of the exon was chosen to capture the hnRNP interactions with
the most potential to affect splicing. While individual hnRNP
CDCs are associated with 5% of constitutive exons on average,
a small but significantly higher 7% on average is observed for AS
exons for each of the six hnRNP proteins (p < 1028, Fisher’s
exact test) (Figure 3B). Consistent with our finding that hnRNP
proteins activate and also repress exon recognition, these re-
sults reveal that hnRNP proteins directly associate with constitu-
tive, but more preferentially AS, exons in human cells. Focusing
on cassette exons that were hnRNP-activated (skipped upon
hnRNP depletion) or hnRNP-repressed (included upon hnRNP
depletion), we observed that an average of 11% of cassettes
harbor a CDC of the regulating hnRNP within 2 kb (Figure S3D).
Although it is likely that not all binding sites are retrieved by the
CLIP procedure, we considered this subset of cassette exons
direct targets of hnRNP proteins. Repeating our analysis with
the quartile of cassette exons that change most strongly, corre-
sponding to exons that are more uniquely regulated by a single
hnRNP protein (Figure S3E), did not alter the fraction of direct
targets (Figure S3F). In agreement with our pair-wise compari-
sons of microarray-detected AS cassette exons, we observe
that hnRNP A1 and M more frequently bind near exons that are
included upon depletion (p < 0.05, Fisher’s exact test), impli-
cating these proteins in direct repression of exon inclusion (Fig-
ure 3C). In contrast, hnRNP proteins A2/B1, F, H1, and U appear
to preferentially bind near exons skipped upon their depletion,
implying that these proteins directly activate exon inclusion.
We also considered what fraction of a particular set of hnRNP-
regulated cassettes contained binding sites for the other hnRNP
proteins within 2 kb of the event. Significant CDCs for any of the
six hnRNP proteins fall within 2 kb of 41% of regulated exons on
average (Figure S3G), and CLIP-seq reads for any of the six
hnRNP proteins fall within 2 kb of 95% of regulated exons on
average (Figure S3H). Furthermore, we observe that binding of
a particular hnRNP to the exons that change upon its depletion172 Cell Reports 1, 167–178, February 23, 2012 ª2012 The Authorsis not significantly enriched over binding to the same exons by
the other hnRNP proteins (Table S2). One notable exception to
this observation is hnRNP M, which shows a 4-fold enrichment
of binding to its regulated events over binding of other hnRNP
proteins to hnRNP M-regulated events. Interestingly, we also
see a 2-fold enrichment of binding by hnRNP M and hnRNP A2/
B1 to hnRNP A1-regulated events. These observations demon-
strate that hnRNP proteins are likely in a dynamic, but overlap-
ping, complex and cooperate highly in the regulation of AS.
RNA Splicing Maps Revealed for hnRNP Proteins
To determinewhether a pattern of position-dependent binding of
the hnRNP proteins is associated with some aspect of AS, we
computed the fraction of hnRNP-activated or hnRNP-repressed
cassette exons that had an overlapping CLIP-seq read at each
flanking nucleotide position. A similar calculation was used to
determine the fraction of binding surrounding exons that re-
mained unchanged during hnRNP depletion. A nonparametric
statistical test was used to identify positions that were signifi-
cantly enriched for hnRNP binding (Figure 4, black dots denote
significant positions p < 0.05, chi-square test). This analysis re-
vealed that each hnRNP had a unique pattern of binding around
exons that it directly regulates. For example, hnRNP A1 signifi-
cantly bound the 30 end of exons that were included upon deple-
tion of hnRNP A1 (i.e., repressed). This observation is consistent
with previous reports that hnRNP A1 binds exonic regions to
repress usage of a nearby 50 splice site (Martinez-Contreras
et al., 2007). In contrast, we have shown that hnRNP A2/B1 pref-
erentially binds activated exonsmore than repressed exons (Fig-
ure 3C) but is found at precise locations within 150 nt up- and
downstream of its repressed exons (Figure 4), suggestive of
a ‘‘looping out’’ model of repression as proposed for the case
of the hnRNP A1 pre-mRNA (Hutchison et al., 2002; Martinez-
Contreras et al., 2006). HnRNP M binds proximal to and within
exons to repress splicing (Figure 3C, Figure 4). HnRNP H1
binding is enriched within the flanking intronic regions of exons
it activates, similar to a recently published study for hnRNP H1
(Katz et al., 2010). In contrast, we also observe hnRNPH1binding
to the exons it activates, consistent with previous findings that
hnRNP H1 binds exons and activates exon inclusion (Caputi
and Zahler, 2002; Chen et al., 1999). Unlike splicing factors that
aremore tissue-specific, such as theNOVAandRBFOXproteins,
the RNA-maps for the hnRNP proteins appear less constrained
proximal to the regulated exons (Licatalosi et al., 2008; Yeo
et al., 2009). We also find that hnRNP proteins are neither en-
riched near exons that are alternatively spliced in a tissue-
specific manner (Figure S4) nor enriched near exons that are
predicted to be alternatively spliced in both human and mouse
(Figure S4, last column). This shows that hnRNP proteins are
not preferentially selected to specify very tissue-specific or
evolutionarily conserved alternative splicing events. This likely
reflects a more general control of RNA metabolism by ubiqui-
tously expressed hnRNP proteins that are dynamically in com-
plex with overlapping activities, including but not limited to AS.
HnRNP Proteins Regulate RNA Binding Proteins
Gene Ontology (GO) analysis of 715 hnRNP RNA targets bound
by all six hnRNP proteins revealed that RNA processing, in
Position relative to cassette exon (nucleotides) hnRNP-activatedhnRNP-repressedP < 0.05
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Figure 4. HnRNP Proteins Bind in a Position-Specific Manner around Cassette Exons
RNA splicing maps showing the fraction of microarray-detected cassette exons with CLIP-seq reads located proximal to activated (positive y axis, blue),
repressed (negative y axis, red), and unaffected cassette exons (reflected on positive and negative y axis, transparent gray). The x axis represents nucleotide
position relative to upstream, cassette, and downstream exons. Light blue shading separates positions that fall in the upstream exon (left, –50 to 0), in the cassette
exon (middle left, 0 to 50; middle right, –50 to 0), and in the downstream exon (right, 0 to 50). Black dots represent nucleotide positions where significantly more
hnRNP-activated cassette exons or hnRNP-repressed cassette exons showed binding, compared to unchanged cassette exons (p < 0.05, chi-square test). The
total counts for activated, unaffected, and repressed exons that were used to generate the maps are listed.
(See also Figure S4.)particular the molecular process of ‘‘RNA splicing’’ (p = 2.63 3
108) and ‘‘mRNA metabolic process’’ (p = 9.11 3 109), are
highly enriched categories. Interestingly, inspection of the list
of genes that have CLIP-seq clusters reveals that hnRNP genes
are targets of hnRNP proteins. Specifically, hnRNP A1, A2/B1,
C, F, H, I, K, L, M, Q, R, and U were bound by at least one of
the six hnRNP proteins assayed, and all of the hnRNP proteins
assayed directly associated with their own transcript (Figure 5A).
The hnRNP proteins often bound to the 30 UTRs of hnRNP
transcripts, which suggests autoregulation of their own tran-
scripts and regulation of other hnRNP transcripts.
To measure the transcript levels of hnRNP genes and other
targets that were not all represented on the splicing microarrays,
we subjected polyA-selected RNA from the cells depleted of
hnRNP expression to strand-specific RNA-seq (Parkhomchuk
et al., 2009). For 25,921 annotated human genes, we computed
the number of uniquely mapped reads per kilobase of exon, per
million mapped reads (RPKM) as a normalized measure of gene
expression in the hnRNP-depleted and control siRNA-treated
293T cells (Mortazavi et al., 2008). The RPKM values reflected
reduced levels of the hnRNP transcripts, consistent with signifi-
cant downregulation at their protein level upon siRNA treatment
(Figure 5B). Interestingly, in several cases we observed signifi-
cant upregulation of other hnRNP proteins upon depletion of a
specific hnRNP protein, such as depletion of hnRNP F leading
to an increase in hnRNP U protein levels. This increase in protein
levels, which is unlikely to be a result of off-target siRNA effects
that would downregulate mRNA levels, appears to be posttran-
scriptional, as relatively little changes in mRNA levels of the
hnRNP genes were observed (Figure 5B). Our findings strongly
suggest that compensatory relationships exist, supporting the
cooperativity of binding and regulation among the hnRNP
proteins. The observation that these compensatory reactionsCare asymmetric (i.e., hnRNP F does not increase upon hnRNP
U depletion) also reveals further complexity in their relationships.
Furthermore, our results here imply that the alternative splicing
changes we discovered by using the microarrays are likely an
underestimate of the AS events that are regulated by an indi-
vidual hnRNP protein due to compensation between hnRNP
proteins.
We then explored specific examples of auto- and cross-regu-
lation of hnRNP proteins. HnRNP A1 has been shown to bind
in vitro and regulate the skipping of its own cassette exon 7B
(Blanchette and Chabot, 1999). The hnRNP A1 isoform contain-
ing exon 7B yields a protein with less splicing activity (Mayeda
et al., 1994). Close to this exon in the hnRNP A1 transcript, we
find an hnRNP U binding site (Figure 5A), suggesting that hnRNP
Umay also contribute to the splicing of exon 7B. Indeed, the use
of RT-PCR to detect the splicing of exon 7B upon hnRNP U
depletion confirms that hnRNP U represses the recognition of
exon 7B (Figure 5C, p < 0.002, t test). Interestingly, we also
find that hnRNP A2/B1, F, and H1 repress this exon, perhaps
indirectly, as there was no significant binding evidence for these
hnRNP proteins or hnRNPA1 near the event in vivo in these cells.
HnRNP A2/B1 has been shown to autoregulate its own ex-
pression levels by splicing of an intron within its 30 UTR that
subsequently results in nonsense-mediated decay (NMD) of
the RNA transcript (McGlincy et al., 2010). Using a splicing-
sensitive quantitative RT-PCR (qRT-PCR) strategy, we demon-
strate that hnRNP A1 also contributes to the splicing of the
hnRNP A2/B1 30 UTR, implicating hnRNP A1 in the regulation
of hnRNP A2/B1 (Figure 5D, p < 0.001, t test). This splicing event
in the hnRNP A2/B1 30 UTR is directly bound only by hnRNP A2/
B1 and hnRNP A1, indicating that the regulation is specific and
direct (Figure 5A). Previous work has proposed that RBPs often
facilitate splicing changes within other RBPs to yield NMDell Reports 1, 167–178, February 23, 2012 ª2012 The Authors 173
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Figure 5. Cross-Regulation of hnRNP Proteins Adds Complexity to Splicing Regulation
(A) CDCs identified for each hnRNP within each of the six hnRNP gene structures. CDCs are shaded according to strength of binding, where darker shading
indicates more significant read coverage. RNA-seq read distributions in control siRNA-treated 293T cells are shown above each hnRNP gene structure.
(B) Quantification of hnRNP protein abundance (based on densitometric measurements of Figure S5 bands) and RNA abundance (based on RNA-seq RPKMs)
within the context of the different hnRNP depletion conditions. Y-values are fold changes over the control protein and RNA levels. Error bars for the protein
quantification are SD in triplicate experiments.
(C) RT-PCR splicing validation of hnRNP A1 exon 7B in each of the hnRNP KD experiments. Bars represent densitometric measurements of bands relative to
control and error bars represent SD in triplicate experiments. Significant changes relative to control are starred (p < 0.002, t test).
(D) Relative expression of an hnRNP A2/B1 spliced 30 UTR NMD candidate isoform in each of the hnRNP KD experiments. Primers ‘‘f’’ and ‘‘r’’ are depicted.
Asterisks denote significant changes relative to control (p < 0.001, t test).
(E) Ratio of relative hnRNP H1 isoform expression with intron removed (measured with primers f1 and r1 depicted) compared to relative hnRNP H1 isoform
expression with intron retained (measured with primers f1 and r2 depicted) in each of the hnRNP KD conditions. Asterisks denote significant changes relative to
control (p < 0.04, t test).
In (D) and (E), relative expression is an averaged abundance by qRT-PCR, with error bars corresponding to SD in triplicate experiments, relative to control. All
measurements are normalized to GAPDH expression.
(See also Figure S5.)candidate transcripts as amechanism of homeostatic control (Ni
et al., 2007). These events can also occur through the inclusion of
an intron or exon containing a premature termination codon174 Cell Reports 1, 167–178, February 23, 2012 ª2012 The Authors(PTC). We also tested another NMD candidate event in which
an intron is retained in the hnRNP H1 transcript, resulting in an
in-frame PTC. This region is of particular interest because it is
strongly bound by hnRNP A1, A2/B1, F, M, and U (Figure 5A).
Using qRT-PCR, we measured the ratio of the hnRNP H1 iso-
forms, one with the intron removed and the other with the intron
retained. Our results reveal that hnRNP A1, A2/B1, M, and U
affect the inclusion of this intron in hnRNP H1 (Figure 5E,
p < 0.04, t test). Notably, the regulation of hnRNP H1 by hnRNP
M correlates with an increase in hnRNP H1 protein levels upon
depletion of hnRNP M (Figure 5B). We conclude that, in addition
to previous literature, hnRNP proteins are subject to autoregula-
tion (Blanchette and Chabot, 1999; McGlincy et al., 2010; Ross-
bach et al., 2009) and that hnRNP proteins cross-regulate each
other, adding to the complexity of the cooperative regulation of
AS by the hnRNP proteins.
Aside from hnRNP genes, other splicing factors from the SR
protein family, such as SRSF1-7, were also direct targets, con-
taining a CDC of at least one hnRNP protein assayed. To identify
whether other pre-mRNA or mRNA binding proteins were direct
targets, we compiled a list of 443 genes containing RNA binding
domains predicted to bind pre-mRNA and mRNA. Interestingly,
70%of the identified RBPs (311 of 443) are bound by at least one
hnRNP protein (p < 1.53 1036, hypergeometric test). Therefore,
hnRNP proteins interact with the RNAs of a significant proportion
of all RBPs. Furthermore, this number of bound RBPs is likely an
underestimate, as hnRNP binding for cell-specific or lowly abun-
dant RBP transcripts may have been missed. HnRNP proteins
also regulate a significant subset of the RNAs encoding RNA
binding proteins (82 of the 311 to which they are bound), at
either the expression or AS level, as detected by splicing array
(p < 1.5 3 105, hypergeometric test) (Figure 6A). Intriguingly,
we detect regulation of RBPs important for the microRNA path-
way, including Drosha, Dicer1, EIF2C1 (Ago1), EIF2C2 (Ago2);
other splicing factors, including, PTBP1 and 2, SRSF5,
NOVA1; and other hnRNP proteins, hnRNPD,DL, K,Q (Syncrip),
and R. For RBP transcripts that are bound and regulated by
multiple hnRNP proteins at the expression level, we consistently
see that all hnRNP proteins tested affect the transcripts in the
same direction, all causing downregulation or all causing upre-
gulation. These findings demonstrated that hnRNP proteins
have regulatory responsibilities and likely play roles in managing
mRNA levels of other RNA binding proteins important for AS and
microRNA-mediated silencing.
Cancer-Associated Genes Are Direct Targets of hnRNP
Proteins
In our analysis of hnRNP-bound transcripts, we also ob-
served strong enrichment for the GO terms ‘‘cell cycle’’
(p < 1.38 3 1022) and ‘‘response to DNA damage stimulus’’
(p < 1.19 3 1018). Widespread misregulation of AS has been
observed in several types of cancer, including lung (Misquitta-
Ali et al., 2011), breast (Lapuk et al., 2010), and colon cancer
(Gardina et al., 2006). Underlying this effect on AS is likely the
misregulation of the levels of hnRNP proteins in cancer
(Carpenter et al., 2006). To identify hnRNP-regulated AS events
within cancer-associated genes, we identified all hnRNP-regu-
lated cassette exons within a set of 368 genes in which specific
mutations are known to contribute to oncogenesis (Futreal et al.,
2004). We found 77 hnRNP-regulated cassette exons that
occurred specifically in these genes, as determined by theCsplicing array. Using the Fluidigm microfluidic multiplex qRT-
PCR platform, we independently validated 41 of the cancer-
associated splicing events (Figure S6).
As hnRNP proteins may bind to targets to regulate other
aspects of RNA processing or other AS events that the arrays
were not designed to interrogate, we searched the 368 cancer-
associated genes for direct hnRNP binding to their pre-mRNAs.
This experiment shows that 71% of the Sanger cancer-associ-
ated genes (261 of 368) have pre-mRNAs that are bound by at
least one hnRNP protein (p < 5.3 3 1032, hypergeometric
test) and 57 of the 261 are significantly regulated by the bound
hnRNP at the expression level and/or the AS level (causing
a change in inclusion of a cassette exon upon depletion of an
hnRNP; p < 0.04, hypergeometric test; Figure 6B). Of the 46
cancer-associated AS events that are regulated by multiple
hnRNP proteins, 39 (85%) are regulated by all hnRNP proteins
in the same splicing direction. This trend again highlights our
finding that many hnRNP proteins regulate RNA processing in
a concerted manner and suggests that hnRNP proteins may
cooperate and have redundant roles to maintain normal cellular
homeostasis, disruption of which can lead to cancer.
DISCUSSION
Cooperative Regulation by hnRNP Proteins
The precise control of RNA processing by RBPs is essential for
maintaining correct gene expression, defects of which can
lead to genetic diseases such as amyotrophic leteral sclerosis
(ALS) or fragile X syndrome, as well as to cancer (Carpenter
et al., 2006; Lagier-Tourenne et al., 2010; Verkerk et al., 1991).
With the emergence of genome-wide methods for detecting
direct binding of RBPs on their RNA substrates, coupled with
technologies to measure changes in RNA processing genome-
wide, a new understanding of the global function of individual
RBPs is emerging. Here, we present a genome-wide analysis
that integrates regulation and binding information for six highly
abundant and ubiquitously expressed RNA binding proteins in
human cells. We have identified 6,555 AS events regulated by
sixmajor hnRNPproteins, A1, A2/B1, H1, F,M, andU, represent-
ing the largest set of RBP-regulated human exons demonstrated
thus far. With this data we have established that these members
of the hnRNP family seem to cooperate with each other in a finely
connected network of regulation, a discovery that would likely be
missed in analysis of a single hnRNP protein.
The hnRNP protein family was first grouped together on the
basis of their abundance and ability to crosslink to RNA;
however, recent studies have debated that perhaps the hnRNP
proteins acted too dissimilarly to be grouped into the same
family (Han et al., 2010). Here, we have shown that the hnRNP
proteins are similar and cooperative in their regulatory roles,
with significant overlap of their bound RNA targets and also in
regulation of sets of AS exons. This is in contrast to the study
in Drosophila of the hnRNP A/B subfamily, which identified
only partial overlapping hnRNP-bound targets (Blanchette
et al., 2009). Interestingly, of common cassette exon targets,
we observed a concordance of effects by hnRNP proteins A2/
B1, F, H1, and U and more opposing effects by hnRNP proteins
A1 and M. Thus, our genome-wide data sets reveal insightsell Reports 1, 167–178, February 23, 2012 ª2012 The Authors 175
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Figure 6. HnRNP Proteins Regulate Other
RBPs and Cancer-Associated Transcripts
Connectivity diagrams of hnRNP-regulated and
hnRNP-bound (A) RNA binding protein transcripts
or (B) cancer-associated transcripts. Nodes re-
present hnRNP RNA targets, and the hnRNP
nodes are enlarged for emphasis. Each edge
represents an hnRNP target that is both bound
directly and regulated, colored according to the
type of regulation. Gray indicates that the gene
contains a cassette exon that changes upon
depletion of the hnRNP. Red and green edges
reflect up- and downregulation of mRNA levels
upon depletion of the hnRNP. Thicker edges re-
present genes with both an alternative cassette
and an expression change.
(See also Figure S6.)governing the cooperativity of hnRNP proteins. Also, resonating
with previous studies (Licatalosi et al., 2008; Mukherjee et al.,
2011; Polymenidou et al., 2011; Sanford et al., 2009; Yeo et al.,176 Cell Reports 1, 167–178, February 23, 2012 ª2012 The Authors2009), we identified that the hnRNP
proteins targeted their own, and in several
cases shown here, other hnRNP pre-
mRNAs, as well as other RBP transcripts.
This regulation of many RBPs, including
many splicing factors (Figure 6A), has
the potential to yield a cascade of direct
and also indirect splicing changes in
human cells when a single hnRNP is
depleted. Consistent with this idea, we
have found that on average less than
50% of the cassette exons have direct
evidence for hnRNP binding (Figure S3G),
suggesting that a portion of the molecular
changes we have observed may be due
to downstream regulation of other regula-
tory factors. For example, hnRNP F regu-
lates theelongation factorELL (Figure 6B),
which in turn could impact a broader
network of RNA processing factors via
polymerase II elongation-coupled effects
on AS (Ip et al., 2011). Further saturation
of our CLIP-seq libraries in the future
may provide more evidence for bound
targets. The absence of detectable
hnRNP binding sites may also be due to
the variability of UV crosslinking effi-
ciency. A smaller-scale study in human
cells previously suggested potential
cross-regulation between the hnRNP
proteins and other RNA binding proteins,
albeit without direct protein-RNA
evidence to support the conclusions
(Venables et al., 2008). In contrast, this
widespread cross-regulation was not
observed in Drosophila cell lines (Blanch-
ette et al., 2009), nor was it observed inanother study of a splicing factor, RBFOX1, in mouse brains
(Gehman et al., 2011). RNA processing, and AS in particular, is
likely far more complex in humans, especially for the abundant,
ubiquitously expressed RBPs such as the hnRNP protein family.
Integrated with AS information, our binding data have also
enabled us to build splicing RNA maps that, as a whole, support
the idea that combinatorial control by hnRNP proteins could be
achieved through direct binding of certain hnRNP proteins
followed by the coordination and recruitment of other hnRNP
proteins to nearby, weakly bound sites (Blanchette et al., 2009).
Targets of hnRNPProteinsEnriched inCancer Pathways
Consistent with the increasing evidence that hnRNP proteins
contribute to cancer pathogenesis, we have discovered that
cancer-associated genes are direct and regulated targets. While
hnRNP proteins have been directly linked to cancer, their specific
mechanisms for affecting tumorigenesis largely remain to be
identified. Here, we have provided a glimpse into cancer-related
pathways that may be specifically targeted in cancers. The direct
mechanism by which the hnRNP proteins interact with these
genes and affect cancer progression remains to be further exam-
ined. We have provided a web resource (http://rnabind.ucsd.
edu/) that enables users to upload sequences within protein-
coding genes, which will be automatically inspected for hnRNP
binding and regulation of AS within the gene. Taken together,
the thousands of hnRNP regulated splicing changes that we
have identified have the potential to provide insight into hnRNP-
regulated splicing events in cancer and other disease systems.
EXPERIMENTAL PROCEDURES
HnRNP A1, A2/B1, F, H1, M, and U were individually depleted in human 293T
cells by transfecting siRNAs at a final concentration of 100 nM (Table S3 for all
siRNA sequences) with Lipofectamine-2000 (Invitrogen). Transfections were
repeated 48 hr later, and cells were harvested in TRIzol (Invitrogen) 72 hr
after the first transfection. Extracted RNA was subjected to splicing-sensitive
microarrays and strand-specific RNA-seq, prepared on the basis of a previ-
ously described method (Parkhomchuk et al., 2009) with minor modifications
(see Extended Experimental Procedures). To acquire RNA targets, untreated
human 293T cells were subjected to UV crosslinking and the frozen lysates
were subjected to the CLIP-seq protocol for hnRNP A1, A2/B1, F, M, or U
as previously described (Yeo et al., 2009), with the use of anti-hnRNP A1
(Novus Biologicals), anti-hnRNP A2/B1 (Santa Cruz Biotechnologies), anti-
hnRNP F (Santa Cruz Biotechnologies), anti-hnRNP M (Aviva Systems
Biology), or anti-hnRNP U (Bethyl Laboratories), respectively. RNA libraries
were subjected to standard Illumina sequencing. Details of computational
analyses are described in Extended Experimental Procedures.
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